Table 1 Demographics and patient characteristics
Parameter | N (%) |
|---|---|
Age group | |
18–34 | 204 (41.9) |
35–49 | 174 (35.7) |
50–64 | 101 (20.7) |
≥ 65 | 8 (1.6) |
Age in years | (mean, SD): 39.09 ± 12.3; (Median, IQR): 37 ± 18 |
Gender | |
Male | 267 (54.8) |
Female | 220 (45.2) |
Ethnicity groups | |
Arab/ Gulf | 160 (32.9) |
Arabs/East Mediterranean& North African | 186 (38.2) |
Asian | 99 (20.3) |
White | 27 (5.5) |
Black African | 15 (3.1) |
Marital Status | |
Married | 181 (37) |
Single | 92 (19) |
Unknown | 214 (44) |
Type of episode | |
First experience of MDD episode | 255 (52) |
Relapse | 206 (42) |
Missing | 26 (5) |
IAD | |
Duloxetine | 25 (5) |
Escitalopram | 211 (43) |
Fluoxetine | 98 (20) |
Fluvoxamine | 1 (0.2) |
Mirtazapine | 38 (7) |
Paroxetine | 20 (4) |
Sertraline | 60 (12) |
Venlafaxine | 29 (6) |
Agomelatine | 5 (0.1) |